Zydus Lifesciences Limited
Company Overview:
Zydus Lifesciences Limited (formerly known as Cadila Healthcare Ltd.) is a leading Indian multinational pharmaceutical company committed to providing affordable and innovative healthcare solutions. Headquartered in Ahmedabad, Gujarat, Zydus operates across the entire pharmaceutical value chain, including research, development, manufacturing, and marketing of a wide range of pharmaceutical products.
Key Highlights:
- Founded: 1952
- Founder: Ramanbhai Patel
- Headquarters: Ahmedabad, Gujarat, India
- Industry: Pharmaceuticals, Biotechnology
- Stock Exchange Listing: NSE & BSE (Ticker: ZYDUSLIFE)
- Global Presence: Over 50 countries including the US, Europe, Latin America, and Asia
- Workforce: Over 23,000 employees globally
Core Business Segments:
- Generic Pharmaceuticals
- Specialty Medicines
- Biologics and Biosimilars
- New Chemical Entities (NCEs)
- Consumer Wellness Products (under Zydus Wellness)
- Animal Health Solutions
Research & Innovation
Zydus Lifesciences is at the forefront of pharmaceutical innovation, with robust R&D capabilities. The company operates multiple state-of-the-art research centers and has made significant investments in:
- Novel Drug Delivery Systems
- Vaccines Development (notably ZyCoV-D, India’s first DNA-based COVID-19 vaccine)
- Biosimilars and Biologics
- Oncology, Cardiology, and Anti-infective Therapies
Manufacturing Excellence
With over 30 manufacturing facilities globally, Zydus Lifesciences complies with global regulatory standards such as:
- USFDA
- WHO-GMP
- EMA
- MHRA (UK)
Sustainability and ESG Focus
Zydus is actively engaged in sustainability efforts, focusing on:
- Green manufacturing processes
- Reduced carbon footprint
- Ethical sourcing and operations
- Community health initiatives
Notable Achievements
Expanding footprint in biotech and specialty medicine sectors.
First Indian pharma company to develop and launch a DNA-based COVID-19 vaccine.
Recognized as one of the top 5 pharmaceutical companies in India.